BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 14613993)

  • 1. Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system.
    Stathopoulou A; Gizi A; Perraki M; Apostolaki S; Malamos N; Mavroudis D; Georgoulias V; Lianidou ES
    Clin Cancer Res; 2003 Nov; 9(14):5145-51. PubMed ID: 14613993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
    Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.
    Pinzani P; Salvadori B; Simi L; Bianchi S; Distante V; Cataliotti L; Pazzagli M; Orlando C
    Hum Pathol; 2006 Jun; 37(6):711-8. PubMed ID: 16733212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
    Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
    Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Levels of cytokeratin CK19 expression in mononuclear blood cells evaluated using a reverse PCR (RT-PCR)].
    López Guerrero JA; Bolufer P; Barragán E; Sanz Alonso M; Palau J; Sempere A; De la Rubia J; Bonanad S; Torregrosa MD
    Sangre (Barc); 1996 Dec; 41(6):441-6. PubMed ID: 9148421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
    Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
    Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time quantitative RT-PCR detection of disseminated endometrial tumor cells in peripheral blood and lymph nodes using the LightCycler System.
    Ji XQ; Sato H; Tanaka H; Konishi Y; Fujimoto T; Takahashi O; Tanaka T
    Gynecol Oncol; 2006 Feb; 100(2):355-60. PubMed ID: 16203027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of occult breast cancer cells by amplification of CK19 mRNA by reverse transcriptase-polymerase chain reaction: role of surgical manipulation.
    Galán M; Viñolas N; Colomer D; Soler G; Muñoz M; Longarón R; Ventura PJ; Gascón P; Estapé J
    Anticancer Res; 2002; 22(5):2877-84. PubMed ID: 12530011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR].
    Zheng HY; Chen Q; Ye YB; Huang WW
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2267-70. PubMed ID: 19087676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of CK19, CK20 and EGFR mRNAs in peripheral blood of carcinoma patients: correlation with clinical stage of disease.
    Gradilone A; Gazzaniga P; Silvestri I; Gandini O; Trasatti L; Lauro S; Frati L; Aglianò AM
    Oncol Rep; 2003; 10(1):217-22. PubMed ID: 12469172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR.
    Ntoulia M; Stathopoulou A; Ignatiadis M; Malamos N; Mavroudis D; Georgoulias V; Lianidou ES
    Clin Biochem; 2006 Sep; 39(9):879-87. PubMed ID: 16925986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood.
    Roncella S; Ferro P; Bacigalupo B; Pronzato P; Tognoni A; Falco E; Gianquinto D; Ansaldo V; Dessanti P; Fais F; Rosai J; Fedeli F
    J Exp Clin Cancer Res; 2005 Jun; 24(2):265-71. PubMed ID: 16110760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer.
    Bozionellou V; Mavroudis D; Perraki M; Papadopoulos S; Apostolaki S; Stathopoulos E; Stathopoulou A; Lianidou E; Georgoulias V
    Clin Cancer Res; 2004 Dec; 10(24):8185-94. PubMed ID: 15623593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer.
    Okegawa T; Kinjo M; Nutahara K; Higashihara E
    J Urol; 2004 Apr; 171(4):1461-6. PubMed ID: 15017198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
    Mühlbauer M; Langenbach N; Stolz W; Hein R; Landthaler M; Buettner R; Bosserhoff AK
    Clin Cancer Res; 1999 May; 5(5):1099-105. PubMed ID: 10353744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
    Taback B; Chan AD; Kuo CT; Bostick PJ; Wang HJ; Giuliano AE; Hoon DS
    Cancer Res; 2001 Dec; 61(24):8845-50. PubMed ID: 11751407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.
    Xenidis N; Ignatiadis M; Apostolaki S; Perraki M; Kalbakis K; Agelaki S; Stathopoulos EN; Chlouverakis G; Lianidou E; Kakolyris S; Georgoulias V; Mavroudis D
    J Clin Oncol; 2009 May; 27(13):2177-84. PubMed ID: 19332733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of cancer cells in peripheral blood of breast cancer patients using reverse transcription-polymerase chain reaction for epidermal growth factor receptor.
    Leitzel K; Lieu B; Curley E; Smith J; Chinchilli V; Rychlik W; Lipton A
    Clin Cancer Res; 1998 Dec; 4(12):3037-43. PubMed ID: 9865918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular detection of breast cancer cells in the peripheral blood of advanced-stage breast cancer patients using multimarker real-time reverse transcription-polymerase chain reaction and a novel porous barrier density gradient centrifugation technology.
    Baker MK; Mikhitarian K; Osta W; Callahan K; Hoda R; Brescia F; Kneuper-Hall R; Mitas M; Cole DJ; Gillanders WE
    Clin Cancer Res; 2003 Oct; 9(13):4865-71. PubMed ID: 14581359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of cancer cells in peripheral blood stem cells of women with breast cancer by RT-PCR and cell culture.
    Krüger WH; Stockschläder M; Hennings S; Aschenbrenner M; Gruber M; Gutensohn K; Löliger C; Gieseking F; Jonat W; Zander AR
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S18-20. PubMed ID: 8899163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.